Immunotherapy for Neuroblastoma
Authors:
- Anupa KudvaAKAnupa Kudva
- Shakeel ModakSMShakeel Modak
- 1 January 2019
- book chapter
- Published by Elsevier
- p. 147-173
Abstract
No abstract availableKeywords
This publication has 162 references indexed in Scilit:
- Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid LeukemiaNew England Journal of Medicine, 2013
- A Landscape of Driver Mutations in MelanomaCell, 2012
- Cancer immunotherapy via dendritic cellsNature Reviews Cancer, 2012
- Immunology in the clinic review series; focus on cancer: glycolipids as targets for tumour immunotherapyClinical and Experimental Immunology, 2012
- Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for NeuroblastomaNew England Journal of Medicine, 2010
- Compartmental intrathecal radioimmunotherapy: results for treatment for metastatic CNS neuroblastomaJournal of Neuro-Oncology, 2009
- Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastomaNature Medicine, 2008
- Line of attack: NK cell specificity and integration of signalsCurrent Opinion in Immunology, 2008
- Up on the tightrope: natural killer cell activation and inhibitionNature Immunology, 2008
- MHC class I molecules and kirs in human history, health and survivalNature Reviews Immunology, 2005